Classical sexually transmitted diseases drive the spread of HIV-1: Back to the future

Journal of Infectious Diseases

Volumn 206, Issue 1, 2012, Pages 1-2

  Cohen, Myron S ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

GONORRHEA; HEALTH CARE FACILITIES AND SERVICES; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION PREVENTION; INFECTION RISK; NEISSERIA GONORRHOEAE; NOTE; POINT OF CARE TESTING; PRIORITY JOURNAL; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYMPTOMATOLOGY; VAGINA DISCHARGE; VIRUS DETECTION; VIRUS PATHOGENESIS; VIRUS SHEDDING; VIRUS TRANSMISSION;

FEMALE; HUMANS; INFLAMMATION; REPRODUCTIVE TRACT INFECTIONS; SEXUALLY TRANSMITTED DISEASES; VAGINAL DISCHARGE;

EID: 84861560325     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis303     Document Type: Note

References (17)

1. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008; 8:447-57.
2. Boily M-C, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-29.
3. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual transmission of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8:553-63.
4. Hughes JP, Baeten JM, Lingappa JR, et al. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 2012; 205:358-65.
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV infection with early antiretroviral therapy. New Eng J Med 2011; 363:493-505.
6. Galvin SR, Cohen MS. Sexual transmission of HIV. Nat Rev Microbiol 2004; 2:33-42.
7. Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
8. Cohen MS, Hoffman I. Sexually transmitted diseases enhance transmission of HIV: no longer a hypothesis. Lancet 1998; 351: 5-7.
9. Padian NS, McCoy SI, Balkus JE, et al. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010; 24:621-35.
10. Mlisana K, Naicker N, Werner L, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 2012; 206:6-14.
11. Pépin J, Sobela F, Khonde N, et al. The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. Bull World Health Org 2006; 84:729-38.
12. Pettifor A, Walsh J, Wilkins V, Raghunathan P. How effective is syndromic management of STDs? A review of current studies. Sex Transm Dis 2000; 7:371-85.
13. Eng TR, Butler WT, eds. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997.
14. Britigan BE, Cohen MS, Sparling PF. Neisseria gonorrhoeae: a model of molecular pathogenesis. N Engl J Med 1985; 312:1683-94.
15. Passmore JS, Roberts L, Werner L, et al. Correlates of risk for HIV infection in the female genital tract. Presented at: Keystone Symposium on HIV Evolution, Genomics, and Pathogenesis, Whistler, Canada, 2011.
16. The End of AIDS? The Economist. 2 June 2011. Available at: http://www.economist. com/node/18774722. Accessed 3 February 2012.
17. Office of the Press Secretary. The White House. The beginning of the end of AIDS. Available at: http://www.whitehouse.gov/thepress-office/2011/12/01/ fact-sheet-beginningend-aids. Accessed 3 February 2012.